Security key
68235C107
Oncocyte Corporation - Common Shares, No Par Value (OCX)
CUSIP: 68235C107
Q2 2023 13F Holders as of 30 Jun 2023
- Security type / class
- Equity / Common Shares, No Par Value
- Total 13F shares
- 91,821,550
- Total 13F value
- $21,118,229
- Share change
- +36,163,919
- SEC-reported price per share
- $0.23
- Number of holders
- 45
- Value change
- +$8,239,978
- Number of buys
- 18
- Number of sells
- 19
- Shares outstanding
- 28,495,649
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2023
Institutions
45
Top holders
10
OCX full security history
Ownership snapshot
Full 13F holder table
Insight Molecular Diagnostics Inc. SEC filings
Insight Molecular Diagnostics Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of OCX - Oncocyte Corporation - Common Shares, No Par Value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
PURA VIDA INVESTMENTS, LLC
Disclosed value leader
BROADWOOD CAPITAL INC
Comparable rows
0/15
Latest evidence
30 Jun 2023
13F
3/4/5
Highest disclosed value: $8,276,550
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
BROADWOOD CAPITAL INC has the largest disclosed position value at $8.28M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BROADWOOD CAPITAL INC's linked filing trail.
Disclosed position value
Top 5
PURA VIDA INVESTMENTS, LLC
$5.02M
BROADWOOD CAPITAL INC
$8.28M
AWM Investment Company, Inc.
$2.4M
VANGUARD GROUP INC
$1.54M
Defender Capital, LLC.
$837.6K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| PURA VIDA INVESTMENTS, LLC |
13F
3/4/5
Company · 10%+ Owner
|
—
mixed-class rows
|
$5,020,488
14,166,163 shares
|
— | 31 Mar 2023 |
| BROADWOOD CAPITAL INC |
13F
Company
|
—
denominator unverified
|
$8,276,550
23,353,697 shares
|
— | 31 Mar 2023 |
| AWM Investment Company, Inc. |
13F
Company
|
—
denominator unverified
|
$2,400,369
6,773,051 shares
|
— | 31 Mar 2023 |
| VANGUARD GROUP INC |
13F
Company
|
—
denominator unverified
|
$1,544,901
4,359,202 shares
|
— | 31 Mar 2023 |
| Defender Capital, LLC. |
13F
Company
|
—
denominator unverified
|
$837,600
2,363,430 shares
|
— | 31 Mar 2023 |
| BlackRock Finance, Inc. |
13F
Company
|
—
denominator unverified
|
$505,157
1,425,386 shares
|
— | 31 Mar 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
45
Shares
91,821,550
Rows available
45
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2023 vs Q1 2023 Across Filers
Q1 2023 holders
51
Q2 2023 holders
45
Holder diff
-6
| Investor | Q1 2023 Shares | Q2 2023 Shares | Share Diff | Share Chg % | Q1 2023 value | Q2 2023 value | Value change | Value Chg % |
|---|